Zelira Therapeutics Ltd (ZLD) — Cash Flow Reinvestment Rate

Latest as of December 2015: 0.23x

Zelira Therapeutics Ltd (ZLD) has a Cash Flow Reinvestment Rate of 0.23x as of December 2015, reinvesting AU$36.80K (capex AU$36.80K ) from operating cash flow of AU$159.61K. See ZLD free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

0.23x

(Capex + Investments) / Operating CF

Total Reinvested

AU$36.80K

Capex + Investments

Operating Cash Flow

AU$159.61K

AUD

Capital Expenditures

AU$36.80K

AUD

Zelira Therapeutics Ltd Cash Flow Reinvestment Rate (2011–2011)

Historical reinvestment intensity for Zelira Therapeutics Ltd across 1 annual periods. For the full cash flow conversion analysis, see ZLD cash flow metrics.

Annual Cash Flow Reinvestment Rate for Zelira Therapeutics Ltd (2011–2011)

Year-by-year capital reinvestment analysis for Zelira Therapeutics Ltd. See Zelira Therapeutics Ltd free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.

Year	Reinvestment Rate	Total Reinvested (AUD)	Operating CF	Capex	YoY Change
2011	0.14x	AU$13.95K	AU$101.92K	AU$13.95K	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow